Analysis and Commentary STEVEN GROSSMAN 5/19/23 Analysis and Commentary STEVEN GROSSMAN 5/19/23 The Macro- and Micro- Budget Processes and Their Impact on FDA Resources Read More Advocacy at a Glance STEVEN GROSSMAN 5/12/23 Advocacy at a Glance STEVEN GROSSMAN 5/12/23 The Alliance Welcomes New Members Read More Analysis and Commentary STEVEN GROSSMAN 5/12/23 Analysis and Commentary STEVEN GROSSMAN 5/12/23 FDA and the Iron Triangle of Deficit Reduction Read More Analysis and Commentary STEVEN GROSSMAN 5/5/23 Analysis and Commentary STEVEN GROSSMAN 5/5/23 Hill Days and the Bumpy FY 24 Appropriations Cycle Read More Advocacy at a Glance STEVEN GROSSMAN 5/5/23 Advocacy at a Glance STEVEN GROSSMAN 5/5/23 Alliance Completes Second Round of Hill Days with Senate Focus Read More Analysis and Commentary STEVEN GROSSMAN 4/28/23 Analysis and Commentary STEVEN GROSSMAN 4/28/23 Top Ten Challenges Facing FDA Read More Advocacy at a Glance STEVEN GROSSMAN 4/28/23 Advocacy at a Glance STEVEN GROSSMAN 4/28/23 Hill Days: House Completed, Senate Up Next! Read More Analysis and Commentary STEVEN GROSSMAN 4/21/23 Analysis and Commentary STEVEN GROSSMAN 4/21/23 Q&A About FDA and the FY 24 Budget/Appropriations Process Read More Advocacy at a Glance STEVEN GROSSMAN 4/21/23 Advocacy at a Glance STEVEN GROSSMAN 4/21/23 We are Excited for Our Upcoming Alliance Hill Days. Please Participate! Read More Analysis and Commentary STEVEN GROSSMAN 4/14/23 Analysis and Commentary STEVEN GROSSMAN 4/14/23 Alliance Testifies to the House and Senate on FY 24 Appropriations Read More Advocacy at a Glance STEVEN GROSSMAN 4/14/23 Advocacy at a Glance STEVEN GROSSMAN 4/14/23 Alliance Hill Days Are Coming Up. Please Participate! Read More Advocacy at a Glance STEVEN GROSSMAN 4/6/23 Advocacy at a Glance STEVEN GROSSMAN 4/6/23 Alliance Hill Days Scheduled for April 25 and 26. Please Participate! Read More Analysis and Commentary STEVEN GROSSMAN 4/6/23 Analysis and Commentary STEVEN GROSSMAN 4/6/23 FDA’s FY 24 Budget Q&A Read More Analysis and Commentary STEVEN GROSSMAN 3/31/23 Analysis and Commentary STEVEN GROSSMAN 3/31/23 Why Participate In Hill Days Read More Advocacy at a Glance STEVEN GROSSMAN 3/30/23 Advocacy at a Glance STEVEN GROSSMAN 3/30/23 Alliance Hill Days Announced & Dr. Shuren Transcript Available Read More Analysis and Commentary STEVEN GROSSMAN 3/24/23 Analysis and Commentary STEVEN GROSSMAN 3/24/23 Answers to Your Questions about FY24 Appropriation Read More Advocacy at a Glance STEVEN GROSSMAN 3/24/23 Advocacy at a Glance STEVEN GROSSMAN 3/24/23 FY24 Appropriation Deadline Approaching Read More Analysis and Commentary STEVEN GROSSMAN 3/17/23 Analysis and Commentary STEVEN GROSSMAN 3/17/23 Alliance Seeks Input on FDA Budget Read More Advocacy at a Glance STEVEN GROSSMAN 3/17/23 Advocacy at a Glance STEVEN GROSSMAN 3/17/23 Califf Slated for Senate Hearing Read More Analysis and Commentary STEVEN GROSSMAN 3/10/23 Analysis and Commentary STEVEN GROSSMAN 3/10/23 More Details on the Administration’s FDA Budget Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 5/19/23 Analysis and Commentary STEVEN GROSSMAN 5/19/23 The Macro- and Micro- Budget Processes and Their Impact on FDA Resources Read More
Advocacy at a Glance STEVEN GROSSMAN 5/12/23 Advocacy at a Glance STEVEN GROSSMAN 5/12/23 The Alliance Welcomes New Members Read More
Analysis and Commentary STEVEN GROSSMAN 5/12/23 Analysis and Commentary STEVEN GROSSMAN 5/12/23 FDA and the Iron Triangle of Deficit Reduction Read More
Analysis and Commentary STEVEN GROSSMAN 5/5/23 Analysis and Commentary STEVEN GROSSMAN 5/5/23 Hill Days and the Bumpy FY 24 Appropriations Cycle Read More
Advocacy at a Glance STEVEN GROSSMAN 5/5/23 Advocacy at a Glance STEVEN GROSSMAN 5/5/23 Alliance Completes Second Round of Hill Days with Senate Focus Read More
Analysis and Commentary STEVEN GROSSMAN 4/28/23 Analysis and Commentary STEVEN GROSSMAN 4/28/23 Top Ten Challenges Facing FDA Read More
Advocacy at a Glance STEVEN GROSSMAN 4/28/23 Advocacy at a Glance STEVEN GROSSMAN 4/28/23 Hill Days: House Completed, Senate Up Next! Read More
Analysis and Commentary STEVEN GROSSMAN 4/21/23 Analysis and Commentary STEVEN GROSSMAN 4/21/23 Q&A About FDA and the FY 24 Budget/Appropriations Process Read More
Advocacy at a Glance STEVEN GROSSMAN 4/21/23 Advocacy at a Glance STEVEN GROSSMAN 4/21/23 We are Excited for Our Upcoming Alliance Hill Days. Please Participate! Read More
Analysis and Commentary STEVEN GROSSMAN 4/14/23 Analysis and Commentary STEVEN GROSSMAN 4/14/23 Alliance Testifies to the House and Senate on FY 24 Appropriations Read More
Advocacy at a Glance STEVEN GROSSMAN 4/14/23 Advocacy at a Glance STEVEN GROSSMAN 4/14/23 Alliance Hill Days Are Coming Up. Please Participate! Read More
Advocacy at a Glance STEVEN GROSSMAN 4/6/23 Advocacy at a Glance STEVEN GROSSMAN 4/6/23 Alliance Hill Days Scheduled for April 25 and 26. Please Participate! Read More
Analysis and Commentary STEVEN GROSSMAN 4/6/23 Analysis and Commentary STEVEN GROSSMAN 4/6/23 FDA’s FY 24 Budget Q&A Read More
Analysis and Commentary STEVEN GROSSMAN 3/31/23 Analysis and Commentary STEVEN GROSSMAN 3/31/23 Why Participate In Hill Days Read More
Advocacy at a Glance STEVEN GROSSMAN 3/30/23 Advocacy at a Glance STEVEN GROSSMAN 3/30/23 Alliance Hill Days Announced & Dr. Shuren Transcript Available Read More
Analysis and Commentary STEVEN GROSSMAN 3/24/23 Analysis and Commentary STEVEN GROSSMAN 3/24/23 Answers to Your Questions about FY24 Appropriation Read More
Advocacy at a Glance STEVEN GROSSMAN 3/24/23 Advocacy at a Glance STEVEN GROSSMAN 3/24/23 FY24 Appropriation Deadline Approaching Read More
Analysis and Commentary STEVEN GROSSMAN 3/17/23 Analysis and Commentary STEVEN GROSSMAN 3/17/23 Alliance Seeks Input on FDA Budget Read More
Advocacy at a Glance STEVEN GROSSMAN 3/17/23 Advocacy at a Glance STEVEN GROSSMAN 3/17/23 Califf Slated for Senate Hearing Read More
Analysis and Commentary STEVEN GROSSMAN 3/10/23 Analysis and Commentary STEVEN GROSSMAN 3/10/23 More Details on the Administration’s FDA Budget Read More
